National Institute of Pharmaceutical Education and Research, Raebareli

Dept. of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India

Dr. Anuj Garg
Department of Pharmaceutics
National Institute of Pharmaceutical Education and Research (NIPER)
ITI Compound, Raebareli-229010, India
Tel No.:  +91-535-2700853 (Ext-206)


  1. Garg A , Bhalala K, Tomar DS, Wahajuddin (2017). In situ single pass intestinal permeability and pharmacokinetic study of developed lumefantrine loaded solid lipid nanoparticles. International Journal of Pharmaceutics, 516, 120-130.

  2. Garg A. and Singh S. (2014). Targeting of eugenol loaded solid lipid nanoparticles to the epidermal layer of human skin. Nanomedicine , 9 (8), 1223-1238 (5.824)

  3. Garg A. and Singh S. (2011). Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. Colloids and Surfaces B: Biointerfaces, 87 280-288 (4.287)

  4. Singh S., Parhi R., and Garg A. (2011).  Formulation of Topical Bioadhesive Gel of Aceclofenac Using 3 Level Factorial Design. Iranian Journal of Pharmaceutical Research. 10(3), 435-445. (0.510)

  5. Garg A., Gupta B., Prakash R., Sanjay Singh. (2010). Preparation and Characterization of Hydroxypropyl-β- Cyclodextrin (Hp-β-CD) Inclusion Complex of Eugenol: Differential Pulse Voltammetry and 1HNMR. Chem. Pharm Bull. 58 (10), 1313-19. (1.564)

  6. Garg A. and Singh S. (2010). Eugenol: A potential phytochemical with multifaceted therapeutic activities.  Pharmacologyonline 2, 108-120. (0.16)

  7. Garg A., Rao V. U., Bindu K., Balasubramaniam J., Singh S..(2009) Solid State Interaction of Raloxifene HCl with Different Hydrophilic Carriers during Co- grinding and Its Effect on Dissolution Rate. Drug Dev.Ind.Pharm. 35, 455-470.  (2.00)

  8. Singh S., Mahendra K., Srivastava A. K., Garg A., Muthu M. S. (2008). Effect of Permeation Enhancers on the Iontophoretic Transport of Timolol Maleate through Rat Skin. Acta Pharmaceutica Sciencia 49(3).


  1. Parhi R., Singh S., Garg A., Suresh P. (2010). Effect of permeation enhancers on in vitro permeation of aceclofenac through abdominal skin of mouse. Indian Drugs. 47(10), 34-40

  2. Garg A., Saxena B., and Singh S. (2010). Lipid Nanoparticles: Site specific targeting and toxicological implications. The Pharmstudent (special issue on drug delivery systems) Vol. XXV.

  3. Book Chapter:

    1. Singh S and Garg A. (2011) Importance of shape and surface characterization of nanoparticles: A case study with Eugenol loaded solid lipid nanoparticles. Advances in Nanotechnology and Applications. Vol. III, Ed. Pillai GK and Tran HT, CENTRA, Sullivan University, Kentucky, USA. Pg-101-111

    2. Anuj Garg. Therapeutic application of nanobiomaterials. (2016). In Novel approaches for drug delivery, Kesarvani Raj K, Sharma Anil K and Kesharvani Rajesh K Ed. Hershey PA, United States. ISBN: 9781522507512 (Hardcover), 9781522507529 (ebook)

    3. Garg A., Bhalala K., Tomar D.S., Wahajuddin., Nanomedicine: emerging trends in malaria. In Nanostructures for antimicrobial therapy, Grumezescu A., Ficai A. Ed. Elsevier. ISBN Print:  9780323461528.  (Accepted)



His research interest primarily include development of nanoparticulate based drug delivery systems, dosage forms for natural bioactives or phytochemicals and improving bioavailability of water insoluble drugs or drug belongs to BCS II and IV category. Some natural bioactives or phytochemicals showed good therapeutic activity but fails in in-vivo testing due to their limited bioavailability or instability.  The research interest of improving bioavailability revolves around the preparation and characterization of nanoparticles and by other means like molecular complexation with cyclodextrins, site specific delivery systems. Site specific delivery system is focused to maximize the absorption by means of increasing residence time at site of maximum absorption or at the site of infection. The main area of research interest also include surface modifications of nanoparticles containing active molecule or drug of interest with active targeting moiety to achieve site specificity or active targeting and their in-vitro and in-vivo characterization studies.

Thus, research interest is focused to increase the therapeutic efficacy or benefit/risk ratio of drugs by means of either improving bioavailability or targeting to particular diseased tissues/cells in body.



PhD.                    2011           Indian Institute of Technology (BHU), Varanasi 
M.Pharm              2007           Indian Institute of Technology (BHU), Varanasi
B.Pharm               2005           Indian Institute of Technology (BHU), Varanasi


Professional Experience:



April, 2011-till date

NIPER, Raebareli